A lab at the center of a longstanding controversy about dangerous virus research has engineered heartier influenza viruses that could streamline vaccine production. The researchers contend that their findings may help bring future pandemics under control faster—but the study also demonstrates the risk of curtailing so-called gain-of-function (GOF) studies, in which viruses are made more transmissible or more pathogenic, the researchers argue.
Office of Strategic Communication